News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
226,946 Results
Type
Article (7163)
Company Profile (16)
Press Release (219767)
Section
Business (63140)
Career Advice (294)
Deals (14768)
Drug Delivery (27)
Drug Development (36795)
Employer Resources (24)
FDA (6415)
Job Trends (4909)
News (121821)
Policy (11632)
Tag
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
Academia (567)
Adcomms (7)
Allergies (35)
Alliances (14756)
ALS (25)
Alzheimer's disease (590)
Antibody-drug conjugate (ADC) (32)
Approvals (6451)
Artificial intelligence (94)
Autoimmune disease (7)
Automation (2)
Bankruptcy (147)
Best Places to Work (4609)
BIOSECURE Act (1)
Biosimilars (17)
Biotechnology (18)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (98)
Cancer (1034)
Cardiovascular disease (59)
Career advice (258)
Career pathing (4)
CAR-T (84)
Cell therapy (208)
Cervical cancer (11)
Clinical research (31032)
Collaboration (277)
Compensation (79)
Complete response letters (6)
COVID-19 (728)
CRISPR (17)
C-suite (65)
Cystic fibrosis (36)
Data (1156)
Denatured (1)
Depression (16)
Diabetes (97)
Diagnostics (2219)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (40)
Drug pricing (41)
Drug shortages (17)
Duchenne muscular dystrophy (36)
Earnings (33154)
Editorial (13)
Employer branding (1)
Employer resources (19)
Events (30787)
Executive appointments (210)
FDA (7006)
Featured Employer (3)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (249)
Gene editing (44)
Generative AI (9)
Gene therapy (121)
GLP-1 (176)
Government (1252)
Grass and pollen (2)
Guidances (32)
Healthcare (6138)
Huntington's disease (4)
IgA nephropathy (13)
Immunology and inflammation (32)
Indications (15)
Infectious disease (784)
Inflammatory bowel disease (58)
Inflation Reduction Act (5)
Influenza (22)
Intellectual property (42)
Interviews (45)
IPO (8023)
IRA (17)
Job creations (570)
Job search strategy (221)
Kidney cancer (7)
Labor market (5)
Layoffs (40)
Leadership (3)
Legal (2096)
Liver cancer (37)
Lung cancer (145)
Lymphoma (68)
Management (7)
Manufacturing (91)
MASH (33)
Medical device (4566)
Medtech (4567)
Mergers & acquisitions (7065)
Metabolic disorders (255)
Multiple sclerosis (32)
NASH (8)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (768)
NextGen: Class of 2025 (1500)
Non-profit (711)
Northern California (1166)
Obesity (130)
Opinion (74)
Ovarian cancer (53)
Pain (32)
Pancreatic cancer (45)
Parkinson's disease (58)
Partnered (4)
Patents (111)
Patient recruitment (54)
Peanut (17)
People (14457)
Pharmaceutical (8)
Pharmacy benefit managers (6)
Phase I (9898)
Phase II (13658)
Phase III (10246)
Pipeline (620)
Podcasts (3)
Policy (29)
Postmarket research (797)
Preclinical (3600)
Press Release (9)
Prostate cancer (44)
Psychedelics (11)
Radiopharmaceuticals (118)
Rare diseases (146)
Real estate (1000)
Recruiting (7)
Regulatory (9086)
Reports (13)
Research institute (509)
Resumes & cover letters (39)
Rett syndrome (2)
RNA editing (2)
RSV (14)
Schizophrenia (24)
Series A (40)
Series B (27)
Service/supplier (2)
Sickle cell disease (20)
Southern California (1009)
Special edition (2)
Spinal muscular atrophy (31)
Sponsored (14)
Startups (675)
Stomach cancer (5)
Supply chain (20)
The Weekly (1)
United States (9770)
Vaccines (162)
Venture capitalists (5)
Webinars (1)
Weight loss (74)
Women's health (6)
Worklife (4)
Date
Today (1)
Last 7 days (316)
Last 30 days (1236)
Last 365 days (16089)
2025 (3574)
2024 (16925)
2023 (19105)
2022 (22251)
2021 (23645)
2020 (21806)
2019 (14441)
2018 (10641)
2017 (11458)
2016 (9546)
2015 (11737)
2014 (8106)
2013 (5880)
2012 (6043)
2011 (6753)
2010 (6216)
Location
Africa (176)
Alabama (15)
Alaska (2)
Arizona (50)
Arkansas (3)
Asia (17500)
Australia (4841)
California (2618)
Canada (1055)
China (214)
Colorado (114)
Connecticut (154)
Delaware (54)
Europe (27814)
Florida (383)
Georgia (67)
Idaho (6)
Illinois (190)
India (18)
Indiana (116)
Japan (84)
Kansas (14)
Kentucky (5)
Louisiana (4)
Maine (34)
Maryland (330)
Massachusetts (1891)
Michigan (50)
Minnesota (98)
Missouri (33)
Montana (11)
Nebraska (8)
Nevada (37)
New Hampshire (36)
New Jersey (905)
New Mexico (3)
New York (837)
North Carolina (374)
North Dakota (2)
Northern California (1166)
Ohio (57)
Oklahoma (1)
Oregon (7)
Pennsylvania (625)
Puerto Rico (4)
Rhode Island (7)
South America (301)
South Carolina (8)
Southern California (1009)
Tennessee (37)
Texas (392)
Utah (64)
Virginia (71)
Washington D.C. (16)
Washington State (325)
West Virginia (2)
Wisconsin (10)
226,946 Results for "mesoblast limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mesoblast Financial Results and Corporate Update Webcast
February 26, 2025
·
2 min read
Press Releases
Dr. Gregory George MD PhD Joins Mesoblast Board
February 24, 2025
·
6 min read
Press Releases
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
March 12, 2025
·
5 min read
Pharm Country
Mesoblast Corporate Presentation at Investor Conference - June 03, 2024
Mesoblast Limited, Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference.
June 2, 2024
·
5 min read
Press Releases
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
February 27, 2025
·
19 min read
Press Releases
Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stromal Cell (MSC) Therapy
December 18, 2024
·
10 min read
Press Releases
Mesoblast to be Added to Nasdaq Biotechnology Index
December 19, 2024
·
5 min read
Policy
Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, confirmed that it will file its Biologics License Application for approval of Ryoncil® in the treatment of children with steroid-refractory acute graft versus host disease with the U.S. Food and Drug Administration next week.
July 1, 2024
·
4 min read
Pharm Country
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
Mesoblast Limited announced it has received firm commitments to complete its pro-rata accelerated non-renounceable entitlement offer that was launched on 4 December, 2023.
March 13, 2024
·
5 min read
Cell therapy
Mesoblast Wins First Mesenchymal Stromal Cell Therapy FDA Approval for GVHD
The approval concludes what has been a difficult regulatory path for Ryoncil, which suffered FDA rejections in 2020 and 2023.
December 19, 2024
·
2 min read
·
Tristan Manalac
1 of 22,695
Next
